Nanosonics (NNCSF) Stock Price, News & Analysis

Company Overview

Nanosonics Limited is an Australia‐based medical technology company specializing in infection prevention solutions for the healthcare sector. Founded in 2001 and headquartered in Sydney, the company is best known for developing and commercializing its proprietary Trophon platform, which provides automated high‐level disinfection of ultrasound probes using sonically activated hydrogen peroxide vapor. Nanosonics holds numerous patents and regulatory approvals across multiple jurisdictions, positioning it as a leader in point‐of‐care decontamination.

The company’s flagship product, Trophon EPR, is designed to address the critical need for rapid, reliable disinfection of endocavity and surface ultrasound transducers. By combining ultrasonic agitation with a unique peroxide formulation, Trophon systems deliver validated disinfection cycles in under seven minutes without manual rinsing or staff exposure to harmful chemicals. In addition to its core Trophon offering, Nanosonics continues to invest in research and development to expand its portfolio of infection prevention technologies and consumable products.

Nanosonics serves a global customer base that includes hospitals, imaging centers, clinics and research institutions across North America, Europe, Asia‐Pacific and select emerging markets. The company’s commercial operations are supported by direct sales teams and a network of distribution partners, enabling broad market coverage and ongoing customer training. Led by an experienced management team and governed by a board of directors with backgrounds in medical devices and healthcare, Nanosonics remains focused on driving adoption of its infection prevention solutions and pursuing strategic growth initiatives.

Key Stats

• Today's Range: $3.06 to $3.06
• 50-Day Range: $2.35 to $3.06
• 52-Week Range: $1.69 to $3.30
• Volume: N/A
• Average Volume: 3,309 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

NNCSF Stock Analysis - Frequently Asked Questions

How have NNCSF shares performed this year?

Nanosonics' stock was trading at $2.10 on January 1st, 2025. Since then, NNCSF stock has increased by 45.6% and is now trading at $3.0575.

How do I buy shares of Nanosonics?

Shares of NNCSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NNCSF
• CIK: N/A
• Web: www.nanosonics.com.au
• Phone: (128) 063-1600
• Fax: N/A
• Employees: 466
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A